{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"196"}],"units":"Participants"}],"description":"Patient reported outcomes related to confirmed COVID-19 infection. COVID-19-related outcomes were assessed through a decentralized approach using patient-reported data collected via study questionnaires. Outcomes included participant-reported COVID-19 infection and related clinical events (e.g., hospitalization).","groups":[{"description":"Diagnosis of multiple myeloma must meet the International Myeloma Working Group criteria.\n\nPatient Reported Outcomes: Patients will be asked to complete baseline, 30-day, and 6-month clinical and patient reported outcome health surveys.","id":"OG000","title":"Diagnosis of Multiple Myeloma and Currently Receiving Active Treatment for Any Phase of the Disease"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"The total enrollment for the study was 201 patients. Although the initial enrollment goal was 200 patients, an additional participant consented before the study was closed to enrollment. However, this participant did not complete any study procedures. Four additional patients either withdrew or did not provide a response for this data variable.","reportingStatus":"POSTED","timeFrame":"During 6 month study period","title":"Patient Reported COVID 19 Related Outcomes on Study","type":"SECONDARY","unitOfMeasure":"Participants"}